The TIMES 2 Testosterone Replacement In Hypogonadal men with either Metabolic Syndrome or type 2 Diabetes study was a multicenter, double blind, randomized, placebo controlled study of the effects of testosterone replacement on insulin resistance and cardiovascular risk factors in hypogonadal men with a previous diagnosis of either type 2 diabetes or metabolic syndrome, in which 220 men, average age 60 years, were randomized to testosterone n 108 or placebo n 112 60 C <a href=http://buycialis.buzz>buy liquid cialis online</a>
|
